Recently, at the Golden Pin Design Award ceremony in Taiwan, China, SOMO International won the prestigious Annual Best Design Award for their self-developed and self-manufactured "Ventilator and Mesh Nebulizer System". This marks the product's fourth global design award, following its previously received German Red Dot Design Award, American IDEA Design Award, and Chinese Golden Reed Industrial Design Award.
The Golden Pin Design Award, which has a 40-year history, is the most prestigious and well-known professional design competition in Taiwan, China. It has been described by the media as the "top design award in the global Chinese market" and the "Oscars of the design industry." This year's awards received nearly 8,000 entries from 30 countries and regions around the world and went through three stages of evaluation before the "Breathing Machine Combined with Mesh Nebulizer System" by SmartTop stood out and won the "Best Design Award of the Year," the highest global honor.
A panel of 102 experts from around the world, including renowned German industrial designer Werner Aisslinger, Dutch interior design master Richard Hutten, renowned Japanese designer Yoshiaki Itoh and architect Sohji Fujimoto, and Zhang Guangmin, regional advisor to the World Design Organization, have deemed Smore's "Breathing Machine Combined with Mesh Nebulizer System" to be an excellent systemic design. The system caters to various needs when using the breathing machine, featuring simple components that are easy to operate and clean. It offers convenience, economy, and efficient functional improvements.
The head of the design team expressed in their acceptance speech that as a global leader in atomization technology, this atomizer incorporates Somor's unique respiratory synchronization technology. It helps doctors achieve high-performance inhalation therapy with minimal dosages of medication for optimal treatment results. This can save over 60% of medication and reduce the economic burden on patients. This embodies the corporate spirit of "Atomization Makes Life Better" of Somor.
Simuol's Respirator Combined with Mesh Nebulizer System
According to reports, the atomization device is equipped with a unique thin film sensor that automatically detects pressure changes within the respiratory system when connected to a ventilator. This triggers the inhalation of the medication, allowing the aerosol to flow through the respiratory system and reach the patient. The atomization stops when the patient exhales, preventing any waste of medication. Additionally, the system offers an efficient connection solution by integrating the controller and atomizer design, eliminating lengthy power cables and simplifying the operation process to prevent any errors. In critical moments, this device could potentially provide patients with additional life-saving time.
It has been reported that Smoore's self-developed and self-manufactured atomizer has won the first medical device award in the global e-vapor industry. This atomizer has obtained 8 patents, including 2 invention patents. The product has obtained relevant registrations and production permits and is expected to be launched to the market soon.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
